Related Experiment Video
Updated: Jan 19, 2026

05:12
Author Spotlight: AQRNA-seq Role in Mapping Small RNAs and Unraveling Protein Translation Mechanisms
Published on: February 2, 2024
1.3K
Improved indel detection in DNA and RNA via realignment with ABRA2
Lisle E Mose1, Charles M Perou1,2, Joel S Parker1,2
1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Bioinformatics (Oxford, England)
|January 17, 2019
Summary
ABRA2 improves insertion and deletion (indel) detection from both DNA and RNA sequencing data. This enhanced variant calling accuracy benefits cancer research, Mendelian disorders, and whole-genome analyses.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- Genomic variant detection is crucial for diagnosing cancer and Mendelian disorders.
- Insertions and deletions (indels) are significant variations impacting gene function.
- Current indel detection methods, especially from RNA-Seq data, require improvement.
Purpose of the Study:
- To introduce ABRA2, an improved version of the ABRA tool for short-read realignment.
- To enhance the accuracy and scalability of indel detection from both RNA and DNA sequencing data.
- To broaden the applicability of variant detection to diverse sequencing types, including whole genomes.
Main Methods:
- ABRA2 is a redesigned implementation supporting realignment of RNA and DNA short reads.
- The tool is implemented using Java and C/C++.
- It offers improved scalability for analyzing human whole genomes.
Main Results:
- ABRA2 demonstrates substantial improvements in indel detection across various data types.
- The tool shows enhanced accuracy for whole genomes, targeted exomes, and transcriptome sequencing.
- It provides broader variant calling accuracy improvements compared to the original ABRA.
Conclusions:
- ABRA2 offers a significant advancement in indel detection for both DNA and RNA sequencing.
- The tool enhances variant calling accuracy across multiple genomic and transcriptomic analyses.
- ABRA2 provides a scalable and accurate solution for genomic variant detection in research and diagnostics.
Related Concept Videos
RNA-seq
11.8K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
11.8K
Mismatch Repair
43.5K
Overview
43.5K
Homologous Recombination
62.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.7K
Base Excision Repair
26.0K
One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
The first step of...
26.0K
Long-patch Base Excision Repair
7.9K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.9K

